OTC Medicines

(PHILADELPHIA) – The Consumer Healthcare Product’s Association’s (CHPA) Health In Hand Educational Foundation held its 9th Annual Gala last night at The Bellevue Hotel in Philadelphia. The widely attended fundraiser brought together 350 attendees from 98 companies across the self-care industry to celebrate and support the Foundation’s critical consumer-focused work to help people live happier, healthier lives through responsible self-care. In addition to highlighting Health In Hand’s key 2024 educational initiatives, the event program also included the announcement of the Foundation’s new board member, Mark Pearson, Reckitt’s Vice President of Marketing Health, and the winners of the 2024 U.S. Self-Care Marketing Awards.

“The president-elect has announced his intention to nominate Robert F. Kennedy, Jr. to serve as Secretary of Health and Human Services. 

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association’s (CHPA) President and CEO Scott Melville released the following statement today in response to FDA’s Proposed Order regarding the status of over-the-counter (OTC) phenylephrine (PE):

Despite the critical role sunscreens play in a healthy self-care routine, some state lawmakers are working to restrict sales of chemical sunscreens and key ingredients due to perceived environmental and human health impacts.

CHPA was pleased to announce today that Dr. Doug Bierer has been honored with its prestigious William Cooley Regulatory & Scientific Affairs Career Achievement Award in recognition of his exceptional service and contributions to the consumer healthcare products industry.

(WASHINGTON, DC) – The Health In Hand Foundation today released the following statement announcing the 2024 U.S. Self-Care Marketing Awards finalists. Winners for each category will be announced at the 9th annual Health In Hand Foundation Gala on November 13 at The Bellevue Hotel in Philadelphia. Specific awards will recognize the strategic innovation and marketing expertise of CHPA member companies across over-the-counter (OTC) medicine, consumer medical device, and dietary supplement categories.

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) today released the following statement after providing input to U.S. House Energy & Commerce Committee Members, U.S. Representatives Larry Bucshon (IN-08) and Diana DeGette (CO-01), following their request for information from industry stakeholders on how Congress can build upon the 21st Century Cures Act and Cures 2.0 to develop and deliver a new generation of treatments:

The Consumer Healthcare Products Association (CHPA), the leading voice advocating to empower self-care by preserving and expanding access to trusted consumer healthcare products, today released the following statement in recognition of International Self-Care Day, which is recognized annually on July 24: